Cancer Flashcards
What factors define cancer and how may this effect treatment?
Anatomic location, causes, susceptibly to treatment - cancer has therefore become increasingly individualised.
What was found about leisure time physical activity and cancer prevention and by what journal?
Moore (2016) JAMA: Prospective study of 12 trials including 1.44 million participants. Results: 90th vs 10th percentile showed 20% of more risk reduction of 13 cancer (Oesphageal, 42%, Liver 27%, Lung 26%) and 7% reduced risk across 26 with higher risk for melanoma (sun) and prostate (screening bias).
What was about leisure time physical activity and secondary cancer risk and by what paper?
Friedenreich (2016) Clinical cancer research journal: 26 Prospective cohort studies showed 37% pooled risk reduction for cancer specific mortality for breast, colon, and prostate cancer
What was found in the After Breast Cancer Pooling Project (2012)
- 25% reduced mortality risk for those meeting PA guideliens
- 22% increased risk for sedentary individuals (<1.5 MET hours/week)
- 35% pooled reduced risk for recurrence
What are cancer survivors?
- Individuals with a history of cancer
Why are randomized trials important in cancer research?
Reduce risk of reverse causation and confounding
What is precision medicine?
Personalised or individualised medicine: Tailoring treatment based on individual’s genes, environment, and lifestyle. Greater exercise benefits for certain subgroups.
What was found about the impact of exercise on treatment-related advsere effects and by what paper?
Cormie (2017) (Epidemiology review): The impact of exercise on cancer mortality, recurrence and treatment related adverse events. 100 studies.
Result: Fewer/less severe adverse effects, improved bone mineral density, improved psych distress (anxiety/depression), Improved quality of life in those exercised more.
What are some ongoing clinical trials in cancer research and briefly describe the methods?
UK CHALLENGE Trial: Supervised 3 year multi-centre programme of exercise aiming to achieve 10-27 MET hour/week. Colon patients who have completed routine treatment.
INTERVAL-GAP4 Trial: High-intensity aerobic and resistance exercise routine over 12-months in 6 centres for metastatic prostate cancer.
What was found about exercise training and VO2 peak in cancer patients and in what paper?
Jones (2011) Oncologist Journal: (2.90 vs -1.02 ml/kg/min) for exercise training group with 571 patients across 6 studies. Best for shorter duration (<4 months) and following completion of adjuvant therapy.
Outline the methods and results from Sweegers and Colleagues and the journal their study was in?
Sweegers and colleagues (2018): 28 randomised controlled trials investigating exercise on upper body muscle strength, lower body muscle strength, lower body muscle function (LMBF) and CRF.
- Small effect on all but larger for when interventions were supervised (all), Session durations >60 minutes (RT) and when 3 sessions a week were included (RT).
Why is promoting exercise important in cancer survivors?
1) 8% of caner survivors derived from accelerometer data met mod-vig PA guidelines
2) Significant comorbidities with 60% of cancer survivors being over 55 such as diabetes, CVD, arthritis, and obesity.
3) Combined effects of cancer-related side effects, aging, and other health conditions present as impaired cardiovascular fitness, functional limitations, and reduced quality of life.
What are some considerations to factor in prior to exercise and exercise testing in and what is the adherence like and what’s the significance of this?
1) Low adherence to guidelines - do not create barriers
2) No testing prior to walking, resistance, or flexibility exercise
3) PAR-Q+
4) Brief cancer history
What should a brief cancer history include in cancer survivors?
1) The type of cancer
2) Whether they are receiving treatment
3) Whether the cancer was removed
4) Treatment/Side effects: Neuropathy, Lymphedema, Ostomy, Bone Metastases. Any other symptom influencing their ability to exercise
When should medical evaluation and/or testing be considered?
1) Those with persistent and significant cancer treatment related side-effects
2) Those with significant comorbidities
3) Those with metastatic disease